Characteristics of vascular involvement in Behçet's disease in Japan: A retrospective cohort study

Clinical and Experimental Rheumatology

Volumn 29, Issue 4 SUPPL. 67, 2011, Pages

  Ideguchi, H ^a   Suda, A ^b,c   Takeno, M ^b   Ueda, A ^b   Ohno, S ^a   Ishigatsubo, Y ^b,d  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c Yokohama Minami Kyosai Hospital   (Japan)

^d YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Beh et's disease; Epidemiology; Immunosuppressants; Japan; Vascular involvement

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; PREDNISONE; WARFARIN; ACETYLSALICYLIC ACID; AZATHIOPRINE; COLCHICINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GLUCOCORTICOID; MERCAPTOPURINE; STEROID;

ANGINA PECTORIS; AORTA ANEURYSM; AORTA VALVE REGURGITATION; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; DEEP VEIN THROMBOSIS; FEMALE; HEMOPTYSIS; HUMAN; JAPAN; MALE; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION; RETROSPECTIVE STUDY; THROMBOPHLEBITIS; UNIVERSITY HOSPITAL; ADULT; AMPUTATION; AORTIC ANEURYSM; AORTIC REGURGITATION; ARTERY THROMBOSIS; BLEEDING; CONTROLLED STUDY; EYE DISEASE; FALSE ANEURYSM; GANGRENE; GASTROINTESTINAL DISEASE; JAPANESE (PEOPLE); LEG VARICOSIS; MAJOR CLINICAL STUDY; MIDDLE AGED; ONSET AGE; RELAPSE; SEX RATIO; SURGICAL MORTALITY; VASCULAR DISEASE;

ADULT; BEHCET SYNDROME; COHORT STUDIES; FEMALE; GASTROINTESTINAL DISEASES; HEART DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JAPAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; VASCULAR DISEASES; YOUNG ADULT;

EID: 80855144529     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. LIE JT: Vascular involvement in Behçet's disease: Arterial and venous and vessels of all sizes. J Rheumatol 1992; 19: 341-3.
2. SAKANE T, TAKENO M, SUZUKI N, INABA G: Behçet's disease. N Engl J Med 1999; 341: 1284-91.
3. KOC Y, GÜLLU1, AKPEK G et al;. Vascular involvement in Behçet's disease. J Rheumatol 1992; 19:402-10.
4. KABBAJ N, BENJELLOUN G, GUEDDARI FZ, DAFIRI R, IMANI F: [vascular involvements in Behçet's disease. Based on 40 patient records]. J Radiol 1993; 74: 649-56.
5. GRANA GIL J, SANCHEZ MEIZOSO MO, FREIRE GONZALEZ M, GALDO FERNANDEZ B: Vascular involvement in Behçet's disease. J Rheumatol 1993; 20: 1991.
6. AL-DALAAN AN, AL BALAA SR, EL RAMAHI K et al.: Behçet's disease in Saudi Arabia. J Rheumatol 1994; 21: 658-61.
7. GURLER A, BOYVAT A, TURSEN U: Clinical manifestations of Behçet's disease: An analysis of 2147 patients. YonseiMedJ 1997; 38: 423-7. (Pubitemid 128516403)
8. KO GY, BYUN JY, CHOI BG, CHO SH: The vascular manifestations of Behçet's disease: Angiographic and ct findings. Br J Radiol 2000; 73: 1270-4. (Pubitemid 32140306)
9. KURAL-SEYAHI E, FRESKO I, SEYAHIN et al.: The long-term mortality and morbidity of Behçet's syndrome: A 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 2003; 82: 60-76. (Pubitemid 36139801)
10. TOHMEA, AOUN N, EL-RASSI B, GHAYAD E: Vascular manifestations of Behçet's disease. Eighteen cases among 140 patients. Joint Bone Spine 2003; 70: 384-9.
11. DUZGUN N, ATES A, AYDINTUG OT, DEMIR O, OLMEZ U: Characteristics of vascular involvement in Behçet's disease. Scand J Rheumatol 2006; 35: 65-8. (Pubitemid 43247259)
12. SARICA-KUCUKOGLU R, AKDAG-KOSE A, KAYABAL1M et al:. Vascular involvement in Behçet's disease: A retrospective analysis of 2319 cases. Int J Dermatol 2006; 45: 919-21. (Pubitemid 44145024)
13. KIKUCHI H, ASAKO K, TAKAYAMA M, KONO H, HIROHATA S, ONO Y: Clinical features of Behçet's disease with vascular involvement. American College of Rheumatology 74 Annual Scientific Meetings. Atlanta, 2010.
14. LAKHANPAL S, TANI K, LIE JT, KATOH K, ISHIGATSUBO Y, OHOKUBO T: Pathologic features of Behçet's syndrome: A review of Japanese autopsy registry data. Hum Pathol 1985; 16: 790-5. (Pubitemid 15040814)
15. SAADOUN D, WECHSLER B, DESSEAUX K et al.: Mortality in Behçet's disease. Arthritis Rheum 2010; 62: 2806-12.
16. HATEMI G, SILMAN A, BANG D et al.: EULAR recommendations for the management of Behçet's disease. Ann Rheum Dis 2008; 67: 1656-62.
17. HAMURYUDAN V, OZYAZGAN Y, HIZLI N et al.: Azathioprine in Behçet's syndrome: Effects on long-term prognosis. Arthritis Rheum 1997; 40: 769-74. (Pubitemid 127744665)
18. CANTINI F, SALVARANI C, NICCOLI L et al.: Treatment of thrombophlebitis of Behçet's disease with low dose cyclosporine A. Clin Exp Rheumatol 1999; 17: 391-2. (Pubitemid 29265696)
19. HAMURYUDAN V, ER T, SEYAHIE et al.: Pulmonary artery aneurysms in Behçet's syndrome. Am J Med 2004; 117: 867-70. (Pubitemid 39602798)
20. MIZUSHIMA Y: Recent research into Behçet's disease in Japan. Int J Tissue React 1988; 10: 59-65.
21. SUZUKI KUROKAWA M, SUZUKI N: Behçet's disease. Clin Exp Med 2004; 4: 10-20.
22. IDEGUCHI H, SUDA A, TAKENO M, UEDA A, OHNO S, ISHIGATSUBO Y: Behçet's disease: Evolution of clinical manifestations. Medicine (Baltimore) 2011; 90: 125-32.
23. CRITERIA FOR DIAGNOSIS OF Behçet's DISEASE: International study group for Behçet's disease. Lancet 1990; 335: 1078-80.
24. WHITE RH, ZHOU H, MURIN S, HARVEY D: Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 2005; 93: 298-305. (Pubitemid 40253735)
25. BERTINA RM, KOELEMAN BP, KOSTER T et al.: Mutation in blood Coagulation factor V associated with resistance to activated protein c. Nature 1994; 369: 64-7. (Pubitemid 24144355)
26. SVENSSON PJ, DAHLBACK B: Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-22. (Pubitemid 24058953)
27. MARGAGLIONE M, BRANCACCIO V, GIULIANI N et al.: Increased risk for venous thrombosis in carriers of the prothrombin g->a20210 gene variant. Ann Intern Med 1998; 129: 89-93. (Pubitemid 28337249)
28. TAKAMIYA O, ISHIDA F, KODAIRA H, KITANO K: Apc-resistance and mnl I genotype (gin 506) of Coagulation factor V are rare in Japanese population. Thromb Haemost 1995; 74: 996.
29. RO A, HARA M, TAKADA A: The factor V Leiden mutation and the prothrombin g20210a mutation was not found in Japanese patients with pulmonary thromboembolism. Thromb Haemost 1999; 82: 1769.
30. HO CH, CHAU WK, HSU HC, GAU JP, CHIH CM: Prevalence of factor V Leiden in the Chinese population. Zhonghua Yi Xue Za Zhi (Taipei) 1999; 62: 875-8.
31. HO CH, CHAU WK, HSU HC, GAU JP, YU TJ: Causes of venous thrombosis in fifty Chinese patients. Am J Hematol 2000; 63: 74-8.
32. RICART JM, VAYÁ A, TODOLIJ et al.: Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern spain and their association with thrombotic events. Thromb Haemost 2006; 95: 618-24.
33. SILINGARDI M, SALVARANI C, BOIARDI L et al.: Factor V Leiden and prothrombin gene g20210a mutations in Italian patients with Behçet's disease and deep vein thrombosis. Arthritis Rheum 2004; 51: 177-83. (Pubitemid 38468699)
34. SHEN MC, LIN JS, TSAY W: Protein C and protein S deficiencies are the most important risk factors associated with thrombosis in Chinese venous thrombophilic patients in Taiwan. Thromb Res 2000; 99: 447-52.
35. MOKDAD AH, FORD ES, BOWMAN BA et al.: Prevalence of obesity, diabetes, and obesityrelated health risk factors, 2001. JAMA 2003; 289: 76-9. (Pubitemid 36026281)
36. KAISER R, CLEVELAND CM, CRISWELL LA: Risk and protective factors for thrombosis in systemic lupus erythematosus: Results from a large, multi-ethnic cohort. Ann Rheum Dis 2009;68:238-41.
37. MOK CC, TANG SS, TO CH, PETRI M: Incidence and risk factors of thromboembolism in systemic lupus erythematosus: A comparison of three ethnic groups. Arthritis Rheum 2005; 52: 2774-82. (Pubitemid 41369106)
38. ISHIKURA K, WADA H, KAMIKURA Y et al.: High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis. Am J Hematol 2004; 76: 338-42. (Pubitemid 38988617)
39. NOJIMA J, KURATSUNE H, SUEHISA E et al.: Acquired activated protein C resistance is associated with the co-existence of anti-prothrombin antibodies and lupus anticoaGÜLant activity in patients with systemic lupus erythematosus. Br J Haematol 2002; 118: 577-83. (Pubitemid 34994666)
40. FIJNHEER R, HORBACH DA, DONDERS RC et al.: Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus. Thromb Haemost 1996; 76:514-7. (Pubitemid 26372003)
41. YANQING H, FANGPING C, QINZHI X et al.: No association between thrombosis and factor v gene polymorphisms in Chinese Han population. Thromb Haemost 2003; 89: 446-51. (Pubitemid 36329233)
42. YASUDA S, ATSUMI T, MATSUURA E et al.: Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: Increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant. Arthritis Rheum 2005; 52: 212-8. (Pubitemid 40129250)
43. ALLI N, GUR G, YALCIN B, HAYRAN M: Patient characteristics in Behçet's disease: A retrospective analysis of 213 Turkish patients during 2001-4. Am J Clin Dermatol 2009; 10:411-8.
44. YAZICI H, TUZUN Y, PAZARLI H, YALCIN B, YURDAKUL S, MUFTUOGLU A: The combined use of hla-b5 and the pathergy test as diagnostic markers of Behçet's disease in Turkey. J Rheumatol 1980; 7: 206-10. (Pubitemid 11222935)
45. HATEMI G, SILMAN A, BANG D et al.: Management of Behçet's disease: A systematic literature review for the european league against rheumatism evidence-based recommendations for the management of Behçet's disease. Ann Rheum Dis 2009; 68: 1528-34.
46. CALAMIA KT, SCHIRMER M, MEL1KOGLU M: Major vessel involvement in Behçet's disease: An update. Curr Opin Rheumatol 2011; 23:24-31.
47. AHN JK, LEE YS, JEON CH, KOH EM, CHA HS: Treatment of venous thrombosis associated with Behçet's disease: Immunosuppressive therapy alone versus immunosuppressive therapy plus antiCoagulation. Clin Rheumatol 2008; 27: 201-5.
48. HAMURYUDAN V, YURDAKUL S, MORAL F et al.: Pulmonary arterial aneurysms in Behçet's syndrome: A report of 24 cases. Br J Rheumatol 1994; 33: 48-51. (Pubitemid 24042036)
49. UZUN O, AKPOLAT T, ERKAN L: Pulmonary vasculitis in Behçet's disease: A cumulative analysis. Chest 2005; 127: 2243-53.
50. HIROHATA S, KIKUCHI H: Histopathology of the ruptured pulmonary artery aneurysm in a patient with Behçet's disease. Clin Exp Rheumatol 2009; 27: S91-5.
51. TAKAHAMA M, YAMAMOTO R, NAKAJIMA R, TADA H: Successful surgical treatment of pulmonary artery aneurysm in Behçet's syndrome. Interact Cardiovasc Thorac Surg 2009; 8: 390-2.
52. SASAKI S, YASUDA K, TAKIGAMI K, SHIIYA N, MATSUI Y, SAKUMA M: Surgical experiences with peripheral arterial aneurysms due to vasculo-Behfet's disease. J Cardiovasc Surg (Torino) 1998; 39: 147-50. (Pubitemid 28242844)
53. KOHNO S, FUJIKAWA M, KANDA T, ASAI S, HIROTA M, SAMESHIMA Y: A case of Behçet's syndrome with rupture of a pulmonary aneurysm: Autopsy findings and a literature review. JpnJMed 1986; 25: 293-300. (Pubitemid 17192663)
54. MEHTA P, LAFFAN M, HASKARD DO: Thrombosis and Behçet's syndrome in non-endemic regions. Rheumatology (Oxford) 2010; 49: 2003-4.
55. SEZEN Y, BUYUKHATIPOGLU H, KUCUKDURMAZ Z, GEYIK R: Cardiovascular involvement in Behçet's disease. Clin Rheumatol 2010; 29: 7-12.
56. O'DUFFY JD: Vasculitis in Behçet's disease. Rheum Dis Clin North Am 1990; 16: 423-31.
57. BLETRY O, MOHATTANE A, WECHSLER B et al.: [cardiac involvement in Behçet's disease. 12 cases]. Presse Med 1988; 17: 2388-91. (Pubitemid 19019699)
58. HUONG DL, WECHSLER B, PAPO T et al.: Endomyocardial fibrosis in Behçet's disease. Ann Rheum Dis 1997; 56: 205-8.